Gimv
gimv.com Direct investor
Gimv is a European investment company listed on Euronext Brussels. It invests directly in companies through four sector platforms and also offers long-term equity investments through its Anchor Investments pillar.
Gimv is a private equity firm headquartered in Antwerp, Belgium. It invests directly in companies, at growth, in consumer, healthcare, smart Industries and sustainable Cities. Its stated cheque size is EUR 20 up to EUR 100 million (platforms); EUR 50 up to 400 million (anchor). 2.1 billion EUR portfolio value under management and 63 portfolio companies, as it reports.
“Gimv is a European investment company, listed on Euronext Brussels. As a recognized market leader, we partner with entrepreneurial and innovative companies in 4 forward-looking investment areas.”
— Gimv, own website
- Layer
- Direct investor
- Type
- Private equity
- Stage
- Growth
- Invests in
- Benelux, France, DACH
- Sectors
- Consumer, Healthcare, Smart Industries, Sustainable Cities
- Cheque size
- EUR 20 up to EUR 100 million (platforms); EUR 50 up to 400 million (anchor)
- Assets under management
- 2.1 billion EUR portfolio value
- Portfolio
- 63 companies
Team, as Gimv publishes it
- Bart Troubleyn Managing Partner - Head Anchor Investments
- Floris van Halder Partner - Gimv Anchor Investments
- Karel Vermeulen Investment Manager (*seconded by WorxInvest)
- Michiel Van Leemput Associate
- Karolien Fieremans Investment Controlling Director
- Aline Loots Multiplatform Analyst
- Jacob Leenknecht Multiplatform Analyst
- Patricia Heymans Management Assistant
Names and roles exactly as listed on gimv.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 26 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- BioGeneration Ventures 2 shared companies: kivubioscience.com, complementtx.com
- BOM (Brabantse Ontwikkelings Maatschappij) 2 shared companies: kivubioscience.com, bioconnection.eu
- Mission BioCapital 2 shared companies: immunostherapeutics.com, mediartx.com
- Andera Partners 2 shared companies: fire1foundry.com, exciva.com
- Sofinnova 1 shared company: biotalys.com
- INKEF Capital 1 shared company: onwd.com
- Runway Growth Capital LLC 1 shared company: onwd.com
- HealthCap 1 shared company: kivubioscience.com
- M Ventures 1 shared company: kivubioscience.com
- Double Point Ventures 1 shared company: immunostherapeutics.com
and 16 more — the graph.
Where this comes from
Every fact above was read from a page Gimv publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.gimv.com/enname, is_investor, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, cheque_size, thesis_quote, thesis_quote_page, description, aum, portfolio_count, status, confidence, layer
- https://www.gimv.com/en/about-gimvlayer, type
- https://www.gimv.com/en/investment-platformssectors
- https://www.gimv.com/en/anchor-investmentspeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 1237 · added 2026-08-28 · link last verified 2026-10-21 · confidence high
Similar investors
- ApheonPrivate equity · Growth – Buyout · Brussels, Belgium
- Groupe Bruxelles Lambert (GBL)Private equity · Growth – Buyout · Brussels, Belgium
- Strada PartnersPrivate equity · Buyout · Antwerp, Belgium
- Buysse & PartnersPrivate equity · Growth · Antwerp, Belgium
- CIM Capital Restruct FundPrivate equity · Buyout · Antwerp, Belgium
- CNBB Equity PartnersPrivate equity · Growth – Buyout · Antwerp, Belgium